Dyadic International Inc (DYAI)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
$0.52+3.89%
Close 2026-09-04 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · DYAI
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of None, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | |
|---|---|---|---|---|---|---|---|---|---|
| Revenues | |||||||||
| Revenues | 3.8 | 3.1 | 3.5 | 2.9 | 2.9 | 2.4 | 1.6 | 1.7 | 1.3 |
| Cost of Revenues | 3.2 | 2.3 | 1.2 | 2.0 | 2.1 | 1.9 | 1.4 | 1.5 | 1.0 |
| Operating Expenses & Income | |||||||||
| R&D Expenses | 1.8 | 2.2 | 2.0 | 3.3 | 4.5 | 8.4 | 3.9 | 3.1 | 2.1 |
| Operating Income | (7.4) | (7.2) | (5.9) | (8.2) | (10.2) | (14.7) | (10.0) | (9.3) | (7.6) |
| Earnings from Continuing Operations | |||||||||
| Interest & Investment Income | 0.2 | 0.3 | — | — | — | — | — | — | — |
| Other Non-Operating Income / Expenses | (0.2) | (0.2) | 0.1 | 1.4 | 0.4 | 1.7 | 0.7 | — | 0.9 |
| Income Tax Expense | — | — | — | — | — | 0.0 | 0.0 | 0.0 | (1.0) |
| Net Income | |||||||||
| Net Income | (7.6) | (7.4) | (5.8) | (6.8) | (9.7) | (13.1) | (9.3) | (8.3) | (5.7) |
| Per Share | |||||||||
| Basic EPS | — | (0.23) | (0.20) | (0.24) | (0.34) | (0.47) | — | — | — |
| Diluted EPS | (0.21) | (0.23) | — | — | — | — | — | — | — |
| Revenue per Share | 0.10 | — | — | — | — | — | — | — | — |
| Basic Weighted Avg Shares | — | — | — | 28.8 | 28.4 | — | — | — | — |
| Diluted Weighted Avg Shares | 36.4 | 32.6 | — | — | — | — | — | — | — |
| Supplemental | |||||||||
| EBIT | (7.4) | (7.2) | (5.9) | (8.2) | (10.2) | (14.7) | (10.0) | (9.3) | (7.6) |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.